Bayer's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Bayer, AG. (BAYRY.PK)

Q1 2012 Earnings Call

April 26, 2012 8:00 am ET


Alexander Rosar - Head, IR.

Marijn Dekkers - CEO

Werner Baumann- CFO

Jörg Reinhardt - Chairman, Bayer HealthCare AG

Sandra Peterson - CEO, Bayer CropScience AG

Patrick Thomas - CEO, Bayer MaterialScience AG


Tim Race - Deutsche Bank

Jeremy Redenius - Sanford Bernstein

Sachin Jain - Merrill Lynch

Richard Vosser - JPMorgan

Michael Leuchten - Barclays Capital

Andrew Baum - Citi

Thomas Gilbert - UBS

Christian Faitz -Macquarie

Florent Cespedes - Exane BNP Paribas

Damien Conover - Morningstar

Ronald Köhler - MainFirst



Ladies and gentlemen, thank you for standing by. Welcome to Bayer's Investor and Analysts Conference Call on the First Quarter 2012 Results. Throughout today's recorded presentation all participants will be in a listen-only mode. The presentation will be followed by a question-and-answer session. (Operator Instructions). I would now like to turn the conference over to Mr. Alexander Rosar, Head of Investor Relations of Bayer AG. Please go ahead, sir.

Alexander Rosar

Thank you, Kele. Ladies and gentlemen, good afternoon and welcome also on behalf of my colleagues to our First Quarter Conference Call. As always, with me on the call are Marijn Dekkers, our CEO, and Werner Baumann, our CFO. HealthCare is represented by Jorg Reinhardt; CropScience by Sandra Peterson; and MaterialScience by Patrick Thomas.

Marijn will start off with a brief summary of the development for the quarter. As always, we assume that you have received and reviewed our documents.

If you liked this article you might like

Towers Watson & Co. - Analyst/Investor Day

Cresud's CEO Discusses F2Q12 Results - Earnings Call Transcript

Ocean Power Technologies Management Discusses Q1 2013 Results - Earnings Call Transcript

Microsemi Corporation - Analyst/Investor Day

Lattice Semiconductor's CEO Presents At Deutsche Bank's DbAccess 2012 Technology Conference (Transcript)